Tamsulosin Hydrochloride 0.4 mg Capsules Under Fasting Conditions
Status:
Completed
Trial end date:
2004-12-01
Target enrollment:
Participant gender:
Summary
The objective of this study is to evaluate the comparative bioavailability between Tamsulosin
Hydrochloride 0.4 mg Capsules (Teva Pharmaceuticals USA) and Flomax® 0.4 mg Capsules
(Boehringer Ingelheim Pharmaceuticals, Inc. USA), after a single-dose in healthy subjects
under fasting conditions.